In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...